SYNB
Putnam BioRevolution ETF · PSE
- Category Equity
- Expense Ratio 0.7%
- Listing Date Sep 30, 2022
- Volume 107.0
- Market Cap (AUM) $5.42M
Performance
+1.56%
1W
+6.23%
1M
+2.98%
3M
+17.25%
6M
+6.38%
YTD
+14.23%
1Y
Top Holdings
-
Name
Symbol%Assets
- Thermo Fisher Scientific Inc.TMO7.79%
- Danaher CorporationDHR7.34%
- NVIDIA CorporationNVDA7.21%
- Alphabet Inc. Class AGOOGL6.23%
- Bio-Rad Laboratories, Inc. Class ABIO5.57%
- Novonesis A/S Unsponsored ADR Class BNVZMY4.73%
- Corteva IncCTVA4.55%
- AbbVie, Inc.ABBV3.80%
- Regeneron Pharmaceuticals, Inc.REGN3.79%
- Eli Lilly and CompanyLLY3.60%
Technical Analysis of SYNB 2024-05-10
Overview:
In analyzing the technical indicators for SYNB over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Indicators...
Recent News & Updates
Page 1 of 1
previousnext